Skip to main content
CareCloud Inc (CCLD)
Computer Software and Services Information Technology
Stock AI

CareCloud Inc. to Participate in 2025 Maxim Growth Summit

Last updated: October 15, 2025
Taurigo

1. Event Overview

CareCloud, Inc. (Nasdaq: CCLD, CCLDO), a leader in healthcare technology solutions, has announced its participation in the upcoming 2025 Maxim Growth Summit. Scheduled for October 22–23, 2025, at the Hard Rock Hotel in New York City, this event will gather industry leaders and innovators to discuss emerging trends and advancements in technology and healthcare.

2. Recognition by Maxim Group

Earlier this year, CareCloud garnered significant recognition from Maxim Group, which named the company its 'Top Healthcare IT Pick for 2025.' This accolade reflects CareCloud’s transformative AI strategy, robust financial performance, and renewed momentum in mergers and acquisitions (M&A). The report emphasized several key aspects of CareCloud’s operations, including its AI Center of Excellence, positive free cash flow, and the resumption of preferred dividends in 2025.

3. Key Discussion Topics for Investors

During the summit, CareCloud will address several pivotal topics that highlight its strategic growth and innovation:

M&A Momentum

CareCloud has made significant strides in the M&A arena, successfully closing four transactions in 2025. Notably, the recent acquisition of Medsphere in late August and the acquisition of HFMA’s MAP App earlier this month are expected to enhance the company’s capabilities and market position.

AI Center of Excellence

Earlier this year, CareCloud launched its AI Center of Excellence, which is projected to scale to approximately 500 AI professionals. This initiative aims to accelerate innovation across various domains, including inpatient and ambulatory electronic health records (EHR), revenue cycle management (RCM), analytics, and patient engagement.

Optimistic 2025 Outlook

CareCloud has raised its 2025 revenue guidance to between $116 million and $118 million, driven by strong execution and operational efficiencies. This optimistic projection suggests a solid business foundation and a commitment to growth.

Index Inclusion

In a significant move to broaden investor awareness, CareCloud has been added to the Russell Microcap® Index. This inclusion is expected to enhance the company’s visibility among potential investors and institutional stakeholders.

4. About CareCloud

CareCloud is dedicated to driving disciplined innovation within the healthcare sector. The company's suite of AI and technology-enabled solutions is designed to enhance financial and operational performance for healthcare providers, streamline clinical workflows, and elevate the patient experience. More than 40,000 providers rely on CareCloud's offerings, which include revenue cycle management, practice management, electronic health records, business intelligence, and patient experience management.

To learn more about CareCloud's products and services, visit their official website at carecloud.com.

5. Conclusion

With its participation in the 2025 Maxim Growth Summit, CareCloud is poised to highlight its strategic initiatives and innovative solutions in the healthcare technology landscape. As the company continues to leverage its AI capabilities and pursue growth through strategic acquisitions, it remains a key player in transforming the delivery of healthcare services.

You may also be interested in:
Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.